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During winter 2014–15, England experienced severe 
strains on acute health services. We investigated whether 
syndromic surveillance could contribute to understanding of 
the unusually high level of healthcare needs. We compared 
trends for several respiratory syndromic indicators from that 
winter to historical baselines. Cumulative and mean inci-
dence rates were compared by winter and age group. All-
age influenza-like illness was at expected levels; however, 
severe asthma and pneumonia levels were above those 
expected. Across several respiratory indicators, cumulative 
incidence rates during 2014–15 were similar to those of pre-
vious years, but higher for older persons; we saw increased 
rates of acute respiratory disease, including influenza-like 
illness, severe asthma, and pneumonia, in the 65–74- and 
>75-year age groups. Age group–specific statistical algo-
rithms may provide insights into the burden on health ser-
vices and improve early warning in future winters.
Winter respiratory pathogens account for a large bur-den of community respiratory illness each year 
(1–3). Increased illness can result in pressures on hospi-
tals, which can lead to local incidents where health ser-
vices cannot meet patient demand, often leading to the 
closure of facilities (4). The elderly have been particularly 
implicated in driving hospital pressures due to increased 
admissions and increased lengths of stay (5). Although a 
wide range of viral and bacterial pathogens circulate each 
winter in the Northern Hemisphere, influenza viruses and 
respiratory syncytial virus (RSV) cause the greatest num-
ber of illnesses, especially among young children and the 
elderly. General practitioner (GP) consultations, emer-
gency department (ED) visits, hospital admissions, and 
deaths all increase during periods of influenza and RSV 
activity: annual winter pressures on healthcare systems 
have been attributed in part to these pathogens (6–10). In 
the United Kingdom, seasonal influenza activity gener-
ally occurs during weeks 40–20 (October–May); the peak 
of activity is commonly December 25–January 1 or early 
January (11). RSV activity is typically more consistent, 
peaking during weeks 48–52 of each year, with evidence 
of a lag between the peaks among young children (week 
48) and the elderly (week 52) (12,13). In the past, sentinel 
GP consultations for influenza-like illness (ILI) have been 
used as the standard for monitoring community-based in-
fluenza activity (14–17). These surveillance systems are 
now commonly interpreted as part of a suite of influenza-
related monitoring systems.
Temporal analysis of GP ILI consultations in the 
United Kingdom has revealed a decreasing trend over the 
past 30 years, with particularly low to moderate activity re-
corded since winter 1999–2000 (14). There were 2 notable 
exceptions: the 2009–10 global pandemic, which saw sub-
stantial out-of-season summer and autumn activity (18); 
and winter 2010–11, when influenza activity reached levels 
higher than in any other winter since the millennium winter 
of 1999–2000 (12,19). To take such long-term trends into 
account, the United Kingdom, in common with many other 
countries in Europe, has implemented a Moving Epidemic 
Method to calculate the preepidemic threshold each sea-
son, with an approach that uses historical data to calculate 
the threshold (20). In more recent seasons, a spectrum of 
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influenza surveillance systems, including virologic indica-
tors, is used to determine levels of influenza activity in the 
community and health effects on the population, such as 
hospital admissions and excess deaths confirmed to be in-
fluenza related.
Public Health England (PHE) coordinates a surveil-
lance program for influenza and other respiratory viruses 
including epidemiologic, virologic, and syndromic surveil-
lance systems (21,22). Syndromic surveillance is the near 
real-time collection, analysis, interpretation, and dissemina-
tion of health-related data to enable the early identification 
of the impact (or absence of impact) of potential human or 
veterinary public health threats that require effective public 
health action (23). In England, PHE coordinates a national 
syndromic surveillance service that delivers daily real-time 
syndromic intelligence from several health data sources 
that have been described previously (21). Anonymized 
health data, including a range of symptoms and syndromes, 
are collected daily from several healthcare service provid-
ers across England. Counts of symptoms and syndromes 
are aggregated into several syndromic indicators (e.g., ILI, 
cough, vomiting, rash).
Moderate levels of influenza activity were seen in the 
community in the United Kingdom during 2014–15. Influ-
enza A(H3N2) was the predominant virus circulating for 
most of the season, with influenza B circulating later in the 
season (22). The impact of A(H3N2) was predominantly 
seen in the elderly, with numerous outbreaks in residential 
care homes. Levels of all-cause excess deaths were also 
statistically much higher, at 5.4% excess deaths above the 
upper threshold (16,415 [95% CI 15,588–17,241] more 
excess deaths) than the last notable significant A(H3N2) 
season of 2008–09, which had 3.2% excess deaths above 
the upper threshold (10,438 [95% CI 9,977–10,964] more 
excess deaths) (22). However, in England there were re-
ports of severe pressures within the National Health Ser-
vice (NHS), particularly in emergency medicine, with more 
ED visits, longer waiting times in EDs, and a shortage of 
acute-care hospital beds (4). The aim of this study was to 
determine, retrospectively, whether syndromic surveillance 
could contribute intelligence toward identifying the under-
lying causes of these issues. We used national data collect-
ed routinely from a range of healthcare sources.
Methods
Study Period
PHE conducts enhanced surveillance of influenza and other 
respiratory viruses in the United Kingdom each winter from 
October (week 40) to May (week 20) (22). For this study, 
we used daily syndromic surveillance data extracted Sep-
tember 29, 2014–May 17, 2015. We extracted data from 
corresponding periods in 2 previous winters (2012–13, 
2013–14) for comparison. To define a more specific period 
of intense winter activity during 2014–15, we selected a 
period of 5 weeks encompassing peak activity (24), cor-
responding to week 51 of 2014 through week 3 of 2015 
(December 15, 2014–January 18, 2015).
Syndromic Surveillance Data
Syndromic surveillance data used in this study included 
general practitioner consultations “in hours,” or during 
practitioners’ regular office hours (GPIH), and “out of 
hours” (GPOOH) services; ED visits from a sentinel net-
work that is part of England’s Emergency Department 
Syndromic Surveillance System (EDSSS); and calls to the 
national NHS 111 telehealth service (21,25,26). We select-
ed respiratory indicators from each data source, including 
ILI, upper and lower respiratory tract infection, acute re-
spiratory infection, and pneumonia (Table 1). We captured, 
analyzed, and interpreted data contemporaneously with the 
study period by epidemiologic, statistical, and risk assess-
ment processes (27,28).
Retrospective Descriptive Epidemiologic Analysis
We examined daily plots of syndromic surveillance data 
to establish trends over the winter period. We analyzed 
data according to the individual data source: incidence 
rates per 100,000 registered patient population (GPIH) or 
syndromic counts as a percentage of the total number of 
counts, where population coverage figures were unavail-
able (GPOOH, EDSSS, NHS 111). We stratified data by 
standard age groups (<1, 1–4, 5–14, 15–44, 45–64, 65–
74, >75 years).
To compare respiratory activity during 2014–15 with 
previous winter seasons, we calculated baselines for each 
data source and syndromic indicator on the basis of avail-
able historic data for the data source. We also calculated 
weekly cumulative incidence plots for selected indicators 
and age groups for week 40 of 2014 through week 20 of 
2015 and compared them to those for previous years.
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Table 1. Syndromic surveillance data source and respiratory 
indicators used in study of an atypical winter respiratory illness 
season, England, 2014–15* 
Source Indicator 
GPIH Upper respiratory tract infection; lower 
respiratory tract infections; influenza-like 
illness; “severe asthma”; pneumonia 
GPOOH Acute respiratory infection; influenza-like 
illness; asthma/wheeze/difficulty 
breathing 
EDSSS Acute respiratory infection; influenza-like 
illness; bronchitis; 
asthma/wheeze/difficulty breathing; 
pneumonia 
NHS 111 Cold/flu; cough; difficulty breathing; 
*EDSSS, Emergency Department Syndromic Surveillance System; GP, 
general practitioner; GPIH, GP in hours; GPOOH, GP out of hours; NHS 
111, National Health Service telehealth service. 
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Statistical Analysis
To establish whether there were any statistically signifi-
cant differences in respiratory syndromic activity between 
2014–15 and other years, we used a nonparametric Mann-
Whitney test to compare mean incidence rates between 
winter 2014–15 and the combined winter periods 2012–13 
and 2013–14. We calculated the mean daily incidence 
of each respiratory indicator by age group for the period 
weeks 51–3 for each data source: the rate for 2014–15 was 
compared with that for the same period during the 2 pre-
ceding winters. We performed all statistical analyses with 
Stata version 13.1 (29).
Results
Trends in Respiratory Indicators 2014–15
The analysis of daily trends of syndromic indicators by all 
ages during the 2014–15 season revealed an increase in ac-
tivity beginning in November 2014, with activity generally 
peaking between week 52 of 2014 and week 1 of 2015. 
There were, however, differences in the timing of peak ac-
tivity: the earliest peak occurred in the GPIH, where the 
7-day moving average of upper respiratory tract infection 
(URTI) consultations peaked on December 22, 2014 (Fig-
ure 1, panel B); the latest peak was also in the GPIH, where 
ILI and pneumonia consultations both peaked on January 5, 
2015 (Figure 1, panel A; Figure 2, panel D).
Compared with historical baseline data, the activity 
of GPIH ILI (for all ages) was below seasonally expected 
levels (as demonstrated by historical baselines; Figure 1, 
panel A), whereas GPIH URTI, EDSSS acute respiratory 
illness, and GPOOH asthma/wheeze/difficulty breathing 
activity was just over baseline levels (Figure 1, pan-
els B, C, and D). However, the levels of GPIH lower 
respiratory tract infection (LRTI) and severe asthma and 
of EDSSS pneumonia were considerably higher than ex-
pected during 2014–15 (Figure 2, panels A–C).
For all-age incidence, GPIH and EDSSS pneumonia, 
GPIH LRTI, EDSSS ILI, and GPIH severe asthma were 
significantly higher (p<0.05) during week 51 of 2014 
through week 3 of 2015 than during the same period in 
the comparator seasons (Table 2; full results in online 
Technical Appendix Table, https://wwwnc.cdc.gov/EID/
article/23/11/16-1632-Techapp1.pdf). Calls to the NHS 
111 line for cold/influenza were significantly higher (p = 
0.009) in 2014–15, but due to the lack of historical data, we 
compared these data to those from 2013–14 only.
Cumulative Incidence of Respiratory Indicators
GPIH ILI all-age rates (Figure 3, panel A) during winter 
of 2012–13 and 2014–15 were similar with respect to 
the cumulative incidence slope, although the total cumu-
lative incidence was greater for 2014–15 (307/100,000 
population for 2012–13 and 339/100,000 population 
for 2014–15). Winter 2013–14 was demonstrably lower 
both in the slope of incidence and the final total cumula-
tive incidence. GP ILI rates were noticeably higher in 
incidence for the 65–74- and >75-year age groups dur-
ing 2014–15 (Figure 4, panel A; Figure 5, panel A); the 
cumulative rates for these age groups during 2014–15 
started to diverge from the other winters during week 
50 of 2014. Similarly, cumulative rates for GPIH severe 
asthma were comparable for all ages between 2014–15 
and 2012–13 but were considerably higher for the 65–
74- and >75-year age groups during 2014–15 (Figure 3, 
panel B; Figure 4, panel B; Figure 5, panel B); these 
rates were also higher for the 15–44- and 45–64-year age 
groups (data not shown).
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Figure 1. Daily incidence of 
acute respiratory indicators 
over winter 2014–15, England. 
A) General practitioner in 
hours (GPIH) influenza-like 
illness consultations; B) 
GPIH upper respiratory tract 
infection consultations; C) acute 
respiratory infection visits; 
D) general practitioner out of 
hours asthma/wheeze/difficulty 
breathing consultations. Vertical 
gray shaded area indicates 
period of peak winter activity 
(week 51 of 2014 through week 
3 of 2015). ED, emergency 
department.
Atypical Winter Respiratory Season, England
The number of ED visits for pneumonia was similar 
between 2013–14 and 2014–15 across all ages and for the 
65–74- and >75-year ages, with activity levels higher than 
observed in 2012–13 (Figure 3, panel C; Figure 4, panel 
C; Figure 5, panel C). GPOOH consultations for asthma/
wheeze/difficulty breathing were similar across all age 
groups and years (Figure 3, panel D; Figure 4, panel D; 
Figure 5, panel D).
For several key indicators, the statistical analysis 
confirmed the significant increases in older age groups 
during 2014–15. Of those indicators without evidence for 
statistically significant differences in the all-age incidence 
over weeks 51–3 between 2014–15 and other years, GPIH 
URTI was significantly higher in the 65–74- (p = 0.010) 
and >75-year (p = 0.002) age groups. Similarly, both 
GPIH ILI (65–74 years, p = 0.007; >75-year, p = 0.005) 
and GPOOH asthma/wheeze/difficulty breathing (65–74 
years, p = 0.028; >75-year, p = 0.020) were significantly 
higher for older age groups (Table 2; online Technical 
Appendix Table). 
Discussion
We have undertaken a retrospective observational analysis 
of syndromic healthcare data that were monitored prospec-
tively, on a daily basis, during winter 2014–15 as part of a 
national real-time syndromic surveillance service. Despite 
other indicators of influenza activity demonstrating mod-
erate activity, although more severe in some instances (in 
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Table 2. Comparison of mean daily rate/percentage of selected respiratory indicators over weeks 51–3 between 2014–15 and 
previous 2 winters, England* 
Syndromic surveillance Age group, y 
Indicator System <1 1–4 5–14 15–44 45–64 65–74 >75 All ages 
URTI GPIH  0.178 0.270 0.540 0.086 0.066 0.010 0.002 0.066 
ARI GPOOH  0.807 0.713 0.903 0.713 0.391 0.111 0.050 0.540 
 EDSSS  0.178 0.624 0.624 0.142 0.037 0.111 0.005 0.142 
ILI GPIH  0.391 0.221 0.462 0.178 0.142 0.007 0.005 0.142 
 GPOOH  0.327 0.327 0.540 0.624 0.713 0.221 0.037 0.462 
 EDSSS  0.480 0.312 0.061 0.010 0.178 0.009 0.019 0.007 
Cold/influenza NHS 111  0.410 0.016 0.009 0.009 0.009 0.009 0.016 0.009 
Fever NHS 111  0.602 0.251 0.009 0.076 0.602 0.175 0.602 0.175 
LRTI GPIH  0.462 0.270 0.327 0.111 0.086 0.020 0.005 0.028 
Pneumonia GPIH  0.037 0.178 0.462 0.002 0.003 0.007 0.002 0.002 
 EDSSS  0.156 0.713 0.266 0.178 0.111 0.066 0.020 0.028 
Cough NHS 111  0.917 0.347 0.117 0.047 0.028 0.028 0.047 0.175 
DB NHS 111  0.347 0.465 0.465 0.175 0.117 0.076 0.028 0.175 
A/W/DB EDSSS  0.221 0.066 0.624 0.391 0.086 0.807 0.391 0.540 
 GPOOH  0.624 1.000 0.462 0.111 0.111 0.028 0.020 0.178 
Asthma GPIH  0.167 0.903 0.178 0.028 0.003 0.005 0.003 0.005 
*Activity during winter 2014–15 is compared to combined mean activity during previous 2 winters and results of Mann-Whitney test are presented as p 
values. Statistically significant (at 95% confidence level) results are in bold. ARI, acute respiratory tract infection; A/W/DB, asthma/wheeze/difficulty 
breathing; DB, difficulty breathing; EDSSS, emergency department syndromic surveillance system; GP, general practitioner; GPIH, GP in hours; GPOOH, 
GP out of hours; ILI, influenza-like illness; LRTI, lower respiratory tract infection; URTI, upper respiratory tract infection. 
 
Figure 2. Daily incidence of 
severe respiratory indicators 
over winter 2014–15, England. 
A) General practitioner  
in hours (GPIH) lower  
respiratory tract infection 
consultations; B) GPIH severe 
asthma consultations;  
C) ED pneumonia visits; D) 
GPIH pneumonia consultations. 
Vertical gray shaded area 
indicates period of peak winter 
activity (week 51 of 2014 
through week 3 of 2015).  
ED, emergency department.
RESEARCH
particular for excess all-cause deaths and respiratory out-
breaks in residential care home settings) (22), the national 
incidence of syndromic GP ILI for all ages and other indi-
cators of community-based respiratory activity (e.g., URTI 
and ARI) were within seasonally expected levels. However, 
unusual activity was seen for certain syndromic conditions, 
including GPIH severe asthma and LRTI, as reported con-
temporaneously during the winter (30). At the time, it was 
unclear what was driving these observations; however, when 
these syndromic surveillance data were further stratified by 
age group and compared between years, it was apparent that 
increases in respiratory activity in the 65–74- and >75-year 
age groups were significantly greater than those seen during 
the previous 2 years. Our results support the hypothesis that 
a particular feature of this winter was the effect of respira-
tory infections in the elderly. The elderly have a higher risk 
for severe respiratory disease and secondary complications, 
resulting in excess hospital admissions (5,8,9).
Another important factor to take into account is that 
the dominant circulating strain in 2014–15 was influenza 
A(H3N2), a strain known to cause more severe disease in 
the elderly compared with other influenza subtypes, result-
ing in higher rates of disease and more severe outcomes in 
the elderly during seasons of predominant A(H3N2) circu-
lation (10,31,32). Although 2014–15 was characterized by 
circulation of antigenically and genetically drifted influenza 
A(H3N2) and B viruses, end-of-season vaccine effectiveness 
estimates ultimately demonstrated an overall effectiveness of 
34%, highlighting that, although effectiveness was subopti-
mal, the vaccine still provided important levels of protection 
to vulnerable populations (33). This finding was in line with 
recently published vaccine effectiveness estimates for this 
generation of inactivated vaccines (34).
The timing of influenza activity can be a contributing 
factor to pressures on health services. In the United King-
dom, peak respiratory admissions for bronchitis usually oc-
cur during week 52 of 1 year through week 2 of the next, 
coinciding with circulation of RSV (12,13). During winters 
in which both influenza and RSV, and therefore ILI and 
bronchitis, circulate concurrently, a higher-than-expected 
number of hospital admissions occur as the number of pa-
tients with respiratory illness is condensed into a shorter, 
more intense period (35). During winter 2014–15, influ-
enza activity breached threshold levels during week 50 of 
2014 and peaked in weeks 1 and 2 of 2015, overlapping 
with the peak of RSV activity. Although RSV is mainly 
known as a cause of bronchiolitis in children, it can also 
be an important cause of illness the elderly, in whom it can 
cause pneumonia and other LRTI (3,36,37).
The peak in GP consultations for severe asthma recorded 
during the winter of 2014–15 was nearly twice the baseline 
level. The increase preceded the increase in GP consultations 
for influenza and affected persons >15 years of age. The as-
sociation between influenza infections and exacerbations of 
asthma has been documented through increased asthma hos-
pital admissions in the elderly (38). However, the high num-
ber of GP consultations for severe asthma compared with 
other respiratory indicators during an influenza epidemic is 
unusual, and further work on the underlying causes of these 
excess consultations may be warranted.
Our study has several limitations. Syndromic sur-
veillance is limited to monitoring and reporting on initial 
symptoms and provisional diagnoses; therefore, the re-
sults of this work cannot be directly linked or attributed to 
individual respiratory pathogens. However, previous com-
parisons of syndromic surveillance data with laboratory 
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Figure 3. Weekly cumulative 
rates of selected respiratory 
indicators for all ages, England, 
winter 2014–15 compared 
with the previous 2 winters. A) 
General practitioner in hours 
(GPIH) influenza-like illness 
consultations; B) GPIH severe 
asthma consultations;  
C) ED pneumonia visits;  
D) general practitioner out of 
hours asthma/wheeze/difficulty 
breathing consultations. Vertical 
gray shaded area indicates 
period of peak winter activity 
(week 51 of 2014 through week 
3 of 2015). ED, emergency 
department.
Atypical Winter Respiratory Season, England
reports has shown that respiratory syndromes are sensi-
tive to individual pathogens and can provide early warn-
ing of seasonal respiratory activity such as influenza and 
RSV (39–43).
In addition, several of the national syndromic surveil-
lance data sources have been established since 2012 and 
therefore had limited historical data available for use in this 
study, which limits the comparison with a larger number of 
winters (21,26). Comparable GP surveillance data with ex-
tensive historical data confirm that influenza activity over 
the last decade has been relatively low, and therefore the 
comparison years were not atypical (14).
The number of winters included in this analysis was 
limited by the availability of surveillance data. Interseason-
al differences in influenza vaccine effectiveness may also 
be a limiting factor when making comparisons; we there-
fore recommend future research to update our findings, in-
cluding more winters and possibly stratifying by vaccine 
effectiveness.
We undertook this retrospective analysis to determine 
the relative burden of respiratory illness during the winter. 
However, to translate this research into the active public 
health service, it is important to understand how to apply 
these results to prospective data analysis. A common limi-
tation of prospective analysis is delayed reporting, which 
can limit the usefulness of these data. However, the PHE 
syndromic surveillance data sources are all obtained in near 
real-time (daily), and the data are recorded consistently and 
completed at the time of the patient event.
Our findings support clinicians, health service man-
agers, and public health bodies not relying on a single in-
dicator of influenza activity to anticipate winter pressures 
on healthcare systems. GP consultations for ILI have 
historically been used as a key indicator of influenza activ-
ity in the community. However, persons with influenza can 
experience a wide range of clinical signs and symptoms 
(6). Our work, and that of others, continues to show that 
several clinical indicators, including ILI, LRTI, and severe 
asthma stratified by age, should be monitored routinely to 
identify expected sources of pressure.
Our work also highlights the importance of ensuring 
high levels of vaccine uptake in groups at higher risk for 
severe disease after influenza infection and also for chil-
dren. The pediatric influenza vaccination program in Eng-
land aims to protect the vaccinated children themselves and 
also, by reducing their rates of infection, reduce transmis-
sion in the population and thus indirectly protect those at 
higher risk for severe disease, such as the elderly and those 
with underlying clinical disease.
In the elderly, influenza accounts for more hospital ad-
missions than RSV (10,36,44), but for those admitted to 
hospital with RSV, length of stay, rates of use of intensive 
care, and mortality rates can be similar to those for influ-
enza patients (36). A growing body of evidence indicates 
that the effect of RSV in older patients is underestimated 
because they are not representatively sampled in the com-
munity. Whereas the contribution of RSV to increased hos-
pital admissions in the winter of 2014–15 is uncertain, it 
may have contributed to the total burden placed on hospi-
tals over that period. Improved testing and recognition of 
the effects of RSV by clinicians, particularly those working 
in geriatric medicine, might improve further understanding 
of this burden.
Underpinning each of the PHE national syndromic 
surveillance data sources are statistical algorithms that con-
temporaneously compare current data to historical data to 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017 1839
Figure 4. Weekly cumulative 
rates of selected respiratory 
indicators in the 65–74-year 
age group, England, winter 
2014–15 compared with  
the previous 2 winters.  
A) General practitioner in hours 
(GPIH) influenza-like illness 
consultations; B) GPIH severe 
asthma consultations;  
C) ED pneumonia visits;  
D) general practitioner out of 
hours asthma/wheeze/difficulty 
breathing consultations. 
Vertical gray shaded area 
indicates period of peak winter 
activity (week 51 of 2014 
through week 3 of 2015).  
ED, emergency department
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determine whether activity is statistically higher and there-
fore requires public health action (27). The results of this 
study suggest that further development of these algorithms 
is needed to include age-specific statistics, that is, to monitor 
statistically significant activity in individual age groups rather 
than in all ages. This extended monitoring would offer a bet-
ter means of providing early warning of increasing seasonal 
influenza severity and enable timelier public health action 
and interventions during future winters similar to 2014–15 
(45). However, any increase in the daily workload required 
to monitor a large number of additional age-specific signals 
must be carefully considered. Using automated statistical al-
gorithms to identify aberrations that require further epidemi-
ologic interrogation can help minimize the impact on health 
systems while maintaining this extended monitoring (27).
The additional strain on the healthcare system during 
2014–15 was experienced particularly in emergency medi-
cine (4); the EDSSS was able to monitor trends at the nation-
al level, but the sentinel nature of this surveillance limited 
its usefulness for identifying and supporting local services. 
Future recruitment of additional EDs to the EDSSS across 
England, enabling expansion of this data source, would fur-
ther facilitate use of local ED surveillance data.
Another area of potential future development is de-
veloping predictions and forecasting models to predict un-
usual activity in the elderly. Certain respiratory diagnoses, 
particularly in primary care and EDs, often peak in children 
with a lag before peaking in the elderly (12,43). It has also 
been shown that within primary care, elderly patients seek 
treatment later in the disease episode when symptoms have 
deteriorated (46). Using these observations, public health 
epidemiologists could monitor early incidence in children 
to model and predict unusual activity in the elderly.
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Figure 5. Weekly cumulative 
rates of selected respiratory 
indicators in the >75-year age 
group, England, winter 2014–15 
compared with the previous 2 
winters. A) General practitioner 
in hours (GPIH) influenza-like 
illness consultations; B) GPIH 
severe asthma consultations;  
C) ED pneumonia consultations; 
D) general practitioner out of 
hours asthma/wheeze/difficulty 
breathing consultations. Vertical 
gray shaded area indicates 
period of peak winter activity 
(week 51 of 2014 through week 
3 of 2015) ED, emergency 
department.
Atypical Winter Respiratory Season, England
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EBOLA: People + Public Health + Political Will  is an investigation of the historic 2014–16 Ebola Fever Virus 
epidemic in West Africa, the United States, and around the world. As the crisis unfolded in Guinea, Liberia, and 
Sierra Leone in 2014, it evolved into both a health and a humanitarian crisis. When it became clear that Ebola could 
potentially spread exponentially, threatening global health security, there was a coordinated, massive response.
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